• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments

  • Print
  • Share
  • E-mail
-
1 to 10 of 16 Results
Document Number CR250322
 
 1 
 2 
 > 
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Amphetamines Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Cannabinoids (THC) Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Phencyclidine (PCP) Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Cocaine metabolites Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Opiates Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Methadone Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Propoxyphene Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Methamphetamines Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Benzodiazepines Toxicology / TDM WAIVED 06/04/2025
Wondfo USA Co, Ltd., SAFElife GO At-Home Drug Screen Cup  
CR250322 K182701 Barbiturates Toxicology / TDM WAIVED 06/04/2025

-
-